WHY FERTILITY CONTROL?  
HISTORY  
THE IDEAL  
IMMUNO-
CONTRACEPTION
 
PZP VACCINE  
HOW MANY ANIMALS?  
ETHICAL ISSUES  
REGULATORY ISSUES  
APPLICATION  
THE FUTURE  
THE RESEARCH TEAM  
FUNDING  
OBTAINING PZP  
BIBLIOGRAPHY  
   
 

Future Research - the PZP Wildlife Contraceptive Group

A One-Inoculation Vaccine

Because of the need to inoculate animals twice the first year, and the difficulty of doing this with wild species, research is proceeding toward a "one-inoculation" vaccine. Such a vaccine would permit a single darting to cause one or more years of contraception. The approach under study incorporates the PZP into a non-toxic, bio-degradable material which can be formed into small pellets. The pellets can be designed to release the vaccine at predetermined times after injection (at one and three months currently) much the way time-release cold pills work. Initial trials were encouraging and continued trials are underway (see Eldridge et al. 1989).

New Adjuvants

The good news is that the PZP vaccine works in most mammalian species because the ZP molecule has been conserved over millions of years of evolution. That means the molecule is similar (but not identical) among the many species of mammals. The bad news is that this similarity across species means that PZP is not very good at causing antibodies to be formed. Thus it must be given with a general immunostimulant, known as an adjuvant. This adjuvant, when given with a specific vaccine, causes the body to make greater concentrations of antibodies against the vaccine. The best available adjuvant, known as Freund's Complete Adjuvant (FCA) also causes false positive tuberculosis tests after injection and this restricts it use in many species. New adjuvants, which do not cause these false TB+ tests must be identified and tested. Several adjuvants are under study at the moment. Success in this area may lead to more relaxed regulation of the vaccine by the FDA (see USDA 1997).

Conjugated PZP

It is also possible to conjugate PZP (attach it) to other immunogenic molecules. Experiments are underway to conjugate PZP to an immunogenic protein known as keyhole limpet hemocyanin, or KLH. Initial tests with PZP-KLH conjugates suggest that this form of the vaccine can lead to cellular immune responses (destruction by white blood cells) rather than humoral responses (interference by antibodies). This in turn may lead to irreversible sterilents as well as more effective contraceptives. The ability to cause sterilization rather than temporary contraception can be a huge advantage with some species in some situations (see Millar et al. 1989).

Improved Marker Darts

Available marker darts have a fair degree of reliability but the various dyes have fallen short of the mark. Deer in particular have a tendency to lick the dye off from the injection site. New and more permanent dyes must be found that will survive attention by the target animal and will persist over at least a three to four week period.

A Genetically Engineered or A Synthetic ZP Vaccine

The ability to produce large quantities of the PZP vaccine at low cost will permit the increased use of this vaccine in wildlife. This is a long-term effort requiring resources well beyond those of our own research group. While this is a desirable goal, its attainment is thought to be rather far off (see Kaul et al. 1996).